checkAd

    DGAP-News  747  0 Kommentare IMD Natural Solutions Receives EUR4 Million Equity Investment from Zhejiang Hisun Pharmaceutical Co., Ltd. for Access to Unique Natural Preservatives Technologies


    DGAP-News: IMD Natural Solutions GmbH / Key word(s): Investment
    IMD Natural Solutions Receives EUR4 Million Equity Investment from
    Zhejiang Hisun Pharmaceutical Co., Ltd. for Access to Unique Natural
    Preservatives Technologies

    31.08.2015 / 10:00

    ---------------------------------------------------------------------

    Press Release

    IMD Natural Solutions Receives EUR4 Million Equity Investment from Zhejiang
    Hisun Pharmaceutical Co., Ltd. for Access to Unique Natural Preservatives
    Technologies

    Dortmund, Germany, and Taizhou City, China, August 31, 2015 - IMD Natural
    Solutions GmbH (INS), a natural product company, today announced a
    collaboration with Zhejiang Hisun Pharmaceutical Co., Ltd. (Hisun;
    SHA:600267) under which INS receives a EUR4 million equity investment and
    provides Hisun access to INS' unique natural product lead discovery
    platform for antimicrobials and antioxidants for the food, beverage and
    personal care industries. Furthermore, INS will benefit from Hisun's
    production know-how and capabilities.

    The investment paves the way for INS to further develop and commercialize
    its innovative antimicrobial preservation product for use in food, beverage
    and personal care applications. It is a new, fermentation-based all-natural
    agent with superior efficacy against yeasts, molds and other microbial
    strains and has shown bioactivity against microbial organisms that have
    adapted to current preservative agents. The collaboration provides Hisun
    access to INS' natural product databases and technology for the
    identification and development of suitable active natural ingredients for
    various life science applications.

    "The investment by Hisun into INS and our access to Hisun's production
    know-how and capabilities are an important step in driving our core product
    towards market entry," said Dr. Thomas Henkel, Managing Director of INS.

    "The combination of INS's natural product platform and product candidates
    with Hisun's production know-how creates a unique platform for the
    development and commercialization of new, innovative products and thus
    strengthens our market position and pipeline potential substantially," said
    Mr. Bai Hua, President and CEO of Hisun.

    About IMD Natural Solutions GmbH
    IMD Natural Solutions GmbH (INS) was founded in 2012 in Dortmund, Germany.
    The management has more than 20 years of experience in the discovery and
    development of active compounds derived from natural products. INS owns
    extensive proprietary natural product and genetic source collections, a
    unique technology platform as well as broad chemical and biological
    databases. INS develops and commercializes innovative ingredients - with a
    special focus on preservative agents - derived from totally natural
    sources. The main target markets are in the food, beverages and personal
    care industries.

    About Zhejiang Hisun Pharmaceuticals
    Founded in 1956, the vision of Zhejiang Hisun Pharmaceuticals Co., Ltd.
    (stock code 600267) is to become "a widely respected international
    pharmaceutical company" by advancing its mission of "persisting in
    pharmaceutical innovation for the benefit of human beings." The Company
    focuses on the integration of pharmaceutical research and development (R&D)
    with production resources in order to provide its global customers with
    outstanding products and services. To date, over 40 of the Company's
    products have passed certification by the FDA (U.S.), EDQM (EU), TGA
    (Australia), KFDA (Korea), etc., and are sold in more than 30 countries
    worldwide. To learn more about Hisun, please visit
    http://www.hisunpharm.com/.

    Contact

    Dr. Thomas Henkel, Managing Director
    IMD Natural Solutions GmbH
    Phone: +49-231-9742-7400
    Email: thomas.henkel@imd-natural-solutions.com
    Internet: www.imd-natural-solutions.com

    Wei Zhang, Secretary of board
    Zhejiang HISUN Pharmaceutical Co., Ltd.
    Phone: +86-0576-88827809
    Email: stock600267@hisunpharm.com
    Internet: www.hisunpharm.com

    Raimund Gabriel, Managing Partner
    MC Services AG
    Phone: +49-89-210228-30
    Email: raimund.gabriel@mc-services.eu
    Internet: www.mc-services.eu



    ---------------------------------------------------------------------

    31.08.2015 Dissemination of a Corporate News, transmitted by DGAP - a
    service of EQS Group AG.
    The issuer is solely responsible for the content of this announcement.

    The DGAP Distribution Services include Regulatory Announcements,
    Financial/Corporate News and Press Releases.
    Media archive at www.dgap-medientreff.de and www.dgap.de

    ---------------------------------------------------------------------


    390439 31.08.2015



    EQS Group AG
    0 Follower
    Autor folgen

    Weitere Artikel des Autors

    Verfasst von EQS Group AG
    DGAP-News IMD Natural Solutions Receives EUR4 Million Equity Investment from Zhejiang Hisun Pharmaceutical Co., Ltd. for Access to Unique Natural Preservatives Technologies DGAP-News: IMD Natural Solutions GmbH / Key word(s): Investment IMD Natural Solutions Receives EUR4 Million Equity Investment from Zhejiang Hisun Pharmaceutical Co., Ltd. for Access to Unique Natural Preservatives Technologies 31.08.2015 / 10:00 …